REFERENCES
- Winocour PH. Microalbuminuria. Br Med J 1992; 304: 1196–7.
- Warram JH, Scott LJ, Hanna LS, Wantman M, Cohen SE, Laffel LMB, Ryan L, Krolewski AS. Progression of microalbuminuria to proteinuria in type 1 diabetes. Nonlinear relationship with hyperglycemia. Diabetes 2000; 49: 94–100.
- Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving H-H, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861–69.
- Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parror M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48: 436–72.
- Remuzzi G, Schieppati A, Ruggenenti P. Nephro-pathy in patients with type 2 diabetes. N Engl J Med 2002; 346: 1145–51.
- Derhaschnig U, Kittler H, Woisetschläger C, Bur A, Herkner H, Hirschl M. Microalbumin measurement alone or calculation of the albu-mine/creatinine ratio for the screening of hyper-tension patients? Nephrol Dial Transplant 2002; 17: 81–85.
- Whicher JT. BCR/IFCC reference material for plasma proteins (CRM470). Clin Biochem 1998; 55: 37–40.
- Rowe DJF, Dawnay A, Watts GF. Microalbumin-uria in diabetes mellitus: review and recommenda-tions for the measurement of albumin in urine. Ann Clin Biochem 1990; 27: 297 — 312.